Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Walgreens Rx Share Growth Outpaces Mail; Strong Pharmacy Sales Continue

This article was originally published in The Pink Sheet Daily

Executive Summary

Pharmacy sales grew 19% during the quarter and the company now represents 13% of the total retail market. Walgreens maintains that it has plenty of growth left.

You may also be interested in...



Walgreens’ 90-Day Rx Option Offered By 75 Employers And Insurers

Advantage90 is attractive to pharmacy benefit managers because it is less costly than mail order programs, Walgreens says. Average price of a 90-day script filled at retail is $20 less than the pharmacy chain’s average price for a mail order prescription.

Partisan Politics Returns To US FDA Congressional Oversight

The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS058917

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel